2-amino-2-(2-(6-octyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethyl)propane-1,3-diol

ID: ALA4750944

PubChem CID: 162652005

Max Phase: Preclinical

Molecular Formula: C23H39NO2

Molecular Weight: 361.57

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCC1CCc2cc(CCC(N)(CO)CO)ccc2C1

Standard InChI:  InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-19-9-11-22-16-20(10-12-21(22)15-19)13-14-23(24,17-25)18-26/h10,12,16,19,25-26H,2-9,11,13-15,17-18,24H2,1H3

Standard InChI Key:  SQKXCOAPPIICFR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
   10.8761   -7.4859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5942   -7.8993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5931   -7.0707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7261   -8.6049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7261   -9.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4395   -9.8407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4395   -8.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1530   -8.6049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1514   -9.4297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8637   -9.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5782   -9.4300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8629   -8.1937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2888   -8.1818    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0451   -8.5156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5693   -8.5882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0121   -9.8449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2982   -9.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5843   -9.8449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8703   -9.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1564   -9.8449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4424   -9.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4037   -8.0669    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3085   -6.6564    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8750   -6.6592    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7274   -9.8431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0135   -9.4297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  4  7  1  0
  5  6  1  0
  6  9  1  0
  8  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 15  1  0
 15 12  2  0
 12  8  1  0
 13 14  1  0
 14  2  1  0
 13 15  1  0
  5 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  2 22  1  0
  3 23  1  0
  1 24  1  0
 21 25  1  0
 25 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4750944

    ---

Associated Targets(Human)

S1PR3 Tclin Sphingosine 1-phosphate receptor Edg-3 (2543 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C8 Tchem Cytochrome P450 2C8 (1492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.57Molecular Weight (Monoisotopic): 361.2981AlogP: 4.16#Rotatable Bonds: 12
Polar Surface Area: 66.48Molecular Species: BASEHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.38CX LogP: 5.29CX LogD: 3.34
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.49Np Likeness Score: 0.83

References

1. Yang MG,Xiao Z,Dhar TG,Xiao HY,Gilmore JL,Marcoux D,Xie JH,McIntyre KW,Taylor TL,Borowski V,Heimrich E,Li YW,Feng J,Fernandes A,Yang Z,Balimane P,Marino AM,Cornelius G,Warrack BM,Mathur A,Wu DR,Li P,Gupta A,Pragalathan B,Shen DR,Cvijic ME,Lehman-McKeeman LD,Salter-Cid L,Barrish JC,Carter PH,Dyckman AJ.  (2016)  Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P Receptor Modulator.,  59  (24.0): [PMID:28002964] [10.1021/acs.jmedchem.6b01433]

Source